Back to Clinical Trials
N/ARecruiting

Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity

Sponsored by Mayo Clinic

About this study

This study is being done to better understand the relationship between inflammation in adipose tissue (AT), abnormal deposition of fat around the liver and how this affects its appearance and function and ultimately insulin resistance.

Where this study is enrolling

Who can participate

Inclusion criteria

  • ✓Undergoing gastric bypass surgery
  • ✓Confirmed AUROC F=0 or F\>2 liver fibrosis
  • ✓Age 30-70 years
  • ✓BMI greater than 40 kg/m2
  • ✓Negative pregnancy test (female only)
  • ✓Lab Values: Normal TSH

Exclusion criteria

  • ✕Autoimmune diseases
  • ✕Hepatitis B or C positive
  • ✕Heavy alcohol use
  • ✕Active smoking history
  • ✕Active cancer history
  • ✕History of asthma
  • ✕History of COPD
  • ✕Taking Plavix or Coumadin
  • ✕Blood donation within past 2 months
  • ✕Glucocorticoid Therapy
  • ✕Taking antihistamine on regular basis

Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.

Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.

Trial data sourced from ClinicalTrials.gov.